Global Diabetic Foot Ulcer (DFU) Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ920149 No. of Pages: 136 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Diabetic Foot Ulcer (DFU) Treatment market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Diabetic Foot Ulcer (DFU) Treatment market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Diabetic Foot Ulcer (DFU) Treatment in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic Medication
The proportion of Biologics in 2018 is about 40.1%, which is the biggest segment.
Market Snapshot, By Application
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers
Diabetic Foot Ulcer (DFU) Treatment is widely used to treat Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. The most proportion of Diabetic Foot Ulcer (DFU) Treatment is Neuropathic Ulcers and the proportion in 2018 is 54.1%.
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
3M
Smith & Nephew
Organogenesis
Molnlycke Health Care
Medline
Integra LifeSciences
Essity (BSN Medical)
ConvaTec
Coloplast
B. Braun
The study objectives of this report are:
To study and analyze the global Diabetic Foot Ulcer (DFU) Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Diabetic Foot Ulcer (DFU) Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Diabetic Foot Ulcer (DFU) Treatment manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetic Foot Ulcer (DFU) Treatment market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Diabetic Foot Ulcer (DFU) Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Diabetic Foot Ulcer (DFU) Treatment are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Diabetic Foot Ulcer (DFU) Treatment Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Diabetic Foot Ulcer (DFU) Treatment Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Diabetic Foot Ulcer (DFU) Treatment
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Diabetic Foot Ulcer (DFU) Treatment Sales Channel and Distributors Analysis
3.3.1 Diabetic Foot Ulcer (DFU) Treatment Sales Channel
3.3.2 Diabetic Foot Ulcer (DFU) Treatment Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Neuropathic Ulcers
3.4.2 Major Buyers in Ischemic Ulcers
3.5 Diabetic Foot Ulcer (DFU) Treatment Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Diabetic Foot Ulcer (DFU) Treatment Type Introduction
4.1.1 Wound Care Dressings
4.1.2 Biologics
4.1.3 Therapy Devices
4.1.4 Antibiotic Medication
4.1.5 The proportion of Biologics in 2018 is about 40.1%, which is the biggest segment.
4.2 Global Diabetic Foot Ulcer (DFU) Treatment Sales by Type 2016-2021
4.3 Global Diabetic Foot Ulcer (DFU) Treatment Revenue by Type 2016-2021
4.4 Global Diabetic Foot Ulcer (DFU) Treatment Price by Type 2016-2021
5 Market Segment: by Application
5.1 Diabetic Foot Ulcer (DFU) Treatment Type Introduction
5.1.1 Neuropathic Ulcers
5.1.2 Ischemic Ulcers
5.1.3 Neuro-ischemic Ulcers
5.1.3 Diabetic Foot Ulcer (DFU) Treatment is widely used to treat Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. The most proportion of Diabetic Foot Ulcer (DFU) Treatment is Neuropathic Ulcers and the proportion in 2018 is 54.1%.
5.2 Global Diabetic Foot Ulcer (DFU) Treatment Sales by Application 2016-2021
5.3 Global Diabetic Foot Ulcer (DFU) Treatment Revenue by Application 2016-2021
5.4 Global Diabetic Foot Ulcer (DFU) Treatment Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Diabetic Foot Ulcer (DFU) Treatment Market by Region
6.1.1 Global Diabetic Foot Ulcer (DFU) Treatment Sales by Regions
6.1.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue by Regions
6.2 North America Diabetic Foot Ulcer (DFU) Treatment Market 2016-2021
6.3 Europe Diabetic Foot Ulcer (DFU) Treatment Market 2016-2021
6.4 Asia Pacific Diabetic Foot Ulcer (DFU) Treatment Market 2016-2021
6.5 South America Diabetic Foot Ulcer (DFU) Treatment Market 2016-2021
6.6 Middle East and Africa Diabetic Foot Ulcer (DFU) Treatment Market 2016-2021
7 North America
7.1 North America Diabetic Foot Ulcer (DFU) Treatment Market by Country 2016-2021
7.1.1 North America Diabetic Foot Ulcer (DFU) Treatment Sales by Country
7.1.2 North America Diabetic Foot Ulcer (DFU) Treatment Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Diabetic Foot Ulcer (DFU) Treatment Market by Country 2016-2021
8.1.1 Europe Diabetic Foot Ulcer (DFU) Treatment Sales by Country
8.1.2 Europe Diabetic Foot Ulcer (DFU) Treatment Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Diabetic Foot Ulcer (DFU) Treatment Market by Country 2016-2021
9.1.1 Asia Pacific Diabetic Foot Ulcer (DFU) Treatment Sales by Country
9.1.2 Asia Pacific Diabetic Foot Ulcer (DFU) Treatment Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Diabetic Foot Ulcer (DFU) Treatment Market by Country 2016-2021
10.1.1 South America Diabetic Foot Ulcer (DFU) Treatment Sales by Country
10.1.2 South America Diabetic Foot Ulcer (DFU) Treatment Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Diabetic Foot Ulcer (DFU) Treatment Market by Country 2016-2021
11.1.1 Middle East and Africa Diabetic Foot Ulcer (DFU) Treatment Sales by Country
11.1.2 Middle East and Africa Diabetic Foot Ulcer (DFU) Treatment Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 3M
12.1.1 3M
Company Information
12.1.2 3M
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.1.3 3M
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 3M
Key Development
12.2 Smith & Nephew
12.2.1 Smith & Nephew
Company Information
12.2.2 Smith & Nephew
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.2.3 Smith & Nephew
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Smith & Nephew
Key Development
12.3 Organogenesis
12.3.1 Organogenesis
Company Information
12.3.2 Organogenesis
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.3.3 Organogenesis
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Organogenesis
Key Development
12.4 Molnlycke Health Care
12.4.1 Molnlycke Health Care
Company Information
12.4.2 Molnlycke Health Care
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.4.3 Molnlycke Health Care
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Molnlycke Health Care
Key Development
12.5 Medline
12.5.1 Medline
Company Information
12.5.2 Medline
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.5.3 Medline
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Medline
Key Development
12.6 Integra LifeSciences
12.6.1 Integra LifeSciences
Company Information
12.6.2 Integra LifeSciences
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.6.3 Integra LifeSciences
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Integra LifeSciences
Key Development
12.7 Essity (BSN Medical)
12.7.1 Essity (BSN Medical)
Company Information
12.7.2 Essity (BSN Medical)
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.7.3 Essity (BSN Medical)
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Integra LifeSciences
Key Development
12.9 Coloplast
12.9.1 Coloplast
Company Information
12.9.2 Coloplast
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.9.3 Coloplast
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Coloplast
Key Development
12.8 ConvaTec
12.8.1 ConvaTec
Company Information
12.8.2 ConvaTec
Diabetic Foot Ulcer (DFU) Treatment Product Portfolio, Specification and Application
12.8.3 ConvaTec
Diabetic Foot Ulcer (DFU) Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 ConvaTec
Key Development
13 Global Diabetic Foot Ulcer (DFU) Treatment Market Forecast by Region by Type and by Application
13.1 Global Diabetic Foot Ulcer (DFU) Treatment Sales, Revenue Forecast 2022-2027
13.2 Global Diabetic Foot Ulcer (DFU) Treatment Forecast by Regions
13.2.1 Global Diabetic Foot Ulcer (DFU) Treatment Sales Forecast by Region 2022-2027
13.2.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue Forecast by Region 2022-2027
13.3 Global Diabetic Foot Ulcer (DFU) Treatment Forecast by Type
13.3.1 Global Diabetic Foot Ulcer (DFU) Treatment Sales Forecast by Type 2022-2027
13.3.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue Forecast by Type 2022-2027
13.3.3 Global Diabetic Foot Ulcer (DFU) Treatment Price Forecast by Type 2022-2027
13.4 Global Diabetic Foot Ulcer (DFU) Treatment Forecast by Application
13.4.1 Global Diabetic Foot Ulcer (DFU) Treatment Sales Forecast by Application 2022-2027
13.4.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue Forecast by Application 2022-2027
13.4.3 Global Diabetic Foot Ulcer (DFU) Treatment Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com